Literature DB >> 25097045

The current and future disease burden of chronic hepatitis C virus infection in Egypt.

Imam Waked1, Waheed Doss2, Manal Hamdy El-Sayed3, Chris Estes4, Homie Razavi4, Gamal Shiha5, Ayman Yosry2, Gamal Esmat2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25097045     DOI： 10.1016/j.ajg.2014.04.003

Source DB:  PubMed          Journal:  Arab J Gastroenterol        ISSN： 1687-1979            Impact factor:   2.076


× No keyword cloud information.
  17 in total

Review 1.  Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program.

Authors:  Wael Abdel-Razek; Mohamed Hassany; Manal Hamdy El-Sayed; Magdy El-Serafy; Wahid Doss; Gamal Esmat; Imam Waked
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-01-29

Review 2.  HCV management in resource-constrained countries.

Authors:  Seng Gee Lim
Journal:  Hepatol Int       Date:  2017-02-21       Impact factor: 6.047

3.  Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir.

Authors:  Takeshi Hatanaka; Satoru Kakizaki; Takuya Kaburagi; Naoto Saito; Sachi Nakano; Yoichi Hazama; Sachiko Yoshida; Yoko Hachisu; Yoshiki Tanaka; Teruo Yoshinaga; Kenji Kashiwabara; Atsushi Naganuma; Yuichi Yamazaki; Toshio Uraoka; Shigeo Nagashima; Masaharu Takahashi; Tsutomu Nishizawa; Kazumoto Murata; Hiroaki Okamoto
Journal:  Intern Med       Date:  2021-12-11       Impact factor: 1.282

Review 4.  APASL consensus statements and recommendation on treatment of hepatitis C.

Authors:  Masao Omata; Tatsuo Kanda; Lai Wei; Ming-Lung Yu; Wang-Long Chuang; Alaaeldin Ibrahim; Cosmas Rinaldi Adithya Lesmana; Jose Sollano; Manoj Kumar; Ankur Jindal; Barjesh Chander Sharma; Saeed S Hamid; A Kadir Dokmeci; Geofferey W McCaughan; Jafri Wasim; Darrell H G Crawford; Jia-Horng Kao; Osamu Yokosuka; George K K Lau; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2016-04-29       Impact factor: 6.047

5.  Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.

Authors:  C Estes; M Abdel-Kareem; W Abdel-Razek; E Abdel-Sameea; M Abuzeid; A Gomaa; W Osman; H Razavi; H Zaghla; I Waked
Journal:  Aliment Pharmacol Ther       Date:  2015-07-22       Impact factor: 8.171

6.  The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.

Authors:  Amr Kandeel; Mohamad Genedy; Samir El-Refai; Anna L Funk; Arnaud Fontanet; Maha Talaat
Journal:  Liver Int       Date:  2016-06-30       Impact factor: 5.828

Review 7.  Hepatitis C in Egypt - past, present, and future.

Authors:  Ahmed Elgharably; Asmaa I Gomaa; Mary Me Crossey; Peter J Norsworthy; Imam Waked; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2016-12-20

8.  Management of hepatitis C genotype 4 in the directly acting antivirals era.

Authors:  Emma Hathorn; Ahmed M Elsharkawy
Journal:  BMJ Open Gastroenterol       Date:  2016-09-30

Review 9.  Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010.

Authors:  Sadaf Ghajarieh Sepanlou; Fatemeh Malekzadeh; Farnaz Delavari; Mohsen Naghavi; Mohammad Hossein Forouzanfar; Maziar Moradi-Lakeh; Reza Malekzadeh; Hossein Poustchi; Akram Pourshams
Journal:  Middle East J Dig Dis       Date:  2015-10

Review 10.  Hepatitis C Virus in North Africa: An Emerging Threat.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Mohamed O Ahmed; Aghnyia A Dau; Mohamed M Agnan
Journal:  ScientificWorldJournal       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.